D.E. Shaw & Co
CLB icon

D.E. Shaw & Co’s Core Laboratories CLB Stock Holding History

D.E. Shaw & Co’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-23,000
Closed -$866K – 3958
2019
Q4 		$866K Buy
+23,000
New +$1.03M ﹤0.01% 3081
2019
Q2 		– Sell
-4,100
Closed -$283K – 3688
2019
Q1 		$283K Sell
4,100
-8,300
-67% -$556K ﹤0.01% 3243
2018
Q4 		$740K Sell
12,400
-15,800
-56% -$1.36M ﹤0.01% 2859
2018
Q3 		$3.27M Hold
28,200
– – ﹤0.01% 1857
2018
Q2 		$3.56M Buy
+28,200
New +$3.43M ﹤0.01% 1778
2015
Q3 		– Sell
-20,800
Closed -$2.37M – 3737
2015
Q2 		$2.37M Sell
20,800
-10,200
-33% -$1.24M ﹤0.01% 2056
2015
Q1 		$3.24M Buy
31,000
+20,800
+204% +$2.22M 0.01% 1683
2014
Q4 		$1.23M Buy
10,200
+200
+2% +$26.3K ﹤0.01% 2666
2014
Q3 		$1.46M Buy
+10,000
New +$1.54M ﹤0.01% 2479
2014
Q1 		– Sell
-10,000
Closed -$1.91M – 4315
2013
Q4 		$1.91M Sell
10,000
-10,000
-50% -$1.86M ﹤0.01% 2569
2013
Q3 		$3.38M Hold
20,000
– – 0.01% 1958
2013
Q2 		$3.03M Buy
+20,000
New +$2.83M 0.01% 1733

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co's CLB Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Core Laboratories (CLB) stake by 29% in Q1 2026, selling an estimated $885K and leaving 118,426 shares worth $1.99M. The position accounts for ﹤0.01% of the portfolio, ranked #2920.

D.E. Shaw & Co first reported a position in CLB in Q2 2013 and has held it in 43 quarters since. The position peaked at $12.8M in Q2 2014. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • D.E. Shaw & Co held 118,426 shares of Core Laboratories worth $1.99M as of Q1 2026.
  • D.E. Shaw & Co sold 49,458 Core Laboratories shares in Q1 2026, an estimated $885K.
  • Core Laboratories made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2920 holding.
  • D.E. Shaw & Co first reported a position in Core Laboratories in Q2 2013 and has held it in 43 quarters since.
  • D.E. Shaw & Co's Core Laboratories position peaked at $12.8M in Q2 2014.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.